BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9891218)

  • 1. Tumor angiogenesis: biology and therapeutic prospects.
    Harris SR; Thorgeirsson UP
    In Vivo; 1998; 12(6):563-70. PubMed ID: 9891218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies.
    Pluda JM
    Semin Oncol; 1997 Apr; 24(2):203-18. PubMed ID: 9129690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.
    Cuevas I; Boudreau N
    Adv Cancer Res; 2009; 103():25-42. PubMed ID: 19854351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation and definition of vascular-targeted therapies.
    Siemann DW; Bibby MC; Dark GG; Dicker AP; Eskens FA; Horsman MR; Marmé D; Lorusso PM
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):416-20. PubMed ID: 15701823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects].
    Vacca A; Ribatti D; Pellegrino A; Dammacco F
    Ann Ital Med Int; 2000; 15(1):7-19. PubMed ID: 10842887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor angiogenesis--a potential target in cancer chemoprevention.
    Bhat TA; Singh RP
    Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in cancer.
    Juczewska M; Chyczewski L
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():86-100. PubMed ID: 9337527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis.
    Folkman J; Ingber D
    Semin Cancer Biol; 1992 Apr; 3(2):89-96. PubMed ID: 1378314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic gene therapy for cancer (review).
    Isayeva T; Kumar S; Ponnazhagan S
    Int J Oncol; 2004 Aug; 25(2):335-43. PubMed ID: 15254730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of angiogenesis in the treatment of tumors.
    Ostrowski K; Kinsner A
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):27-31. PubMed ID: 11266087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
    Plavetić ND; Letilović T; Vrbanec D
    Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.
    Dutour A; Rigaud M
    Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of integrins in tumor angiogenesis.
    Hwang R; Varner J
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):991-1006, vii. PubMed ID: 15474331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anti-angiogenic strategies in pediatric solid malignancies: agents and biomarkers of a near future.
    Taylor M; Rössler J; Geoerger B; Vassal G; Farace F
    Expert Opin Investig Drugs; 2010 Jul; 19(7):859-74. PubMed ID: 20470190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor angiogenesis].
    Bussolino F
    Recenti Prog Med; 1999 Jan; 90(1):28-36. PubMed ID: 10193163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current strategies and future directions of antiangiogenic tumor therapy.
    Zhang ZL; Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.